[Federal Register Volume 82, Number 170 (Tuesday, September 5, 2017)]
[Notices]
[Pages 41972-41973]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18670]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Government-Owned Inventions; Availability for Licensing

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Availability for licensing U.S. Government owned intellectual 
property for commercial development.

FOR FURTHER INFORMATION CONTACT: Licensing information and copies of 
the patent applications listed below may be obtained by emailing the 
indicated licensing contact at the National Heart, Lung, and Blood, 
Office of Technology Transfer and Development Office of Technology 
Transfer, 31 Center Drive Room 4A29, MSC2479, Bethesda, MD 20892-2479; 
telephone: 301-402-5579. A signed Confidential Disclosure Agreement may 
be required to receive copies of the patent applications.

SUPPLEMENTARY INFORMATION: The inventions listed below are owned by an 
agency of the U.S. Government and are available for licensing in the 
U.S. in accordance with 35 U.S.C. 209 and 37 CFR part 404 to achieve 
expeditious commercialization of results of federally-funded research 
and development. Foreign patent applications are filed on selected 
inventions to extend market coverage for companies and may also be 
available for licensing. Technology description follows.

Hybrid Computed Tomography Scanning System

    Description of Technology: The invention relates to a combination 
hybrid computed tomography (CT) system that is particularly suited for 
elucidating stages in pulmonary diseases, notably cystic fibrosis and 
lung cancer. Improved visualization of lung parenchyma and the margins 
of lung cysts and lung nodules (non-invasive ``virtual biopsy'') may 
provide sufficient detail to distinguish the types of cystic lesions 
and lung nodules such that the typical lung tissue pathologic biopsy 
would not be needed to make a diagnosis. The system includes placing 
one or more x-ray detector panels near the patient's body initially 
outside the view of a CT scanner and then moved into place for a 
secondary scan. An initial low dose scan, CT scan or X-ray, can be 
performed and if a high-resolution CT scan is then necessary a flat 
panel detector is positioned near the area of interest. It is 
preferable that the flat panel detector be transparent to high-energy 
x-ray photons. The plurality of acquired images are then reconstructed 
into a low and high-resolution image.

Potential Commercial Applications:
     Non-invasive lung biopsies
Development Stage:
     Early stage, no prototype.
Inventors: Han Wen (NHLBI)
Intellectual Property: HHS Reference No. E-175-2017/0-US-01
     U.S. Provisional Patent Application 62/546,639 filed 
August 17, 2017.


[[Page 41973]]


    Licensing Contact: Michael Shmilovich, Esq, CLP; 301-435-5019; 
[email protected].
    Collaborative Research Opportunity: The National Heart, Lung, and 
Blood Institute seeks statements of capability or interest from parties 
interested in collaborative research to further develop and evaluate, 
please contact Cecilia Pazman, Ph.D., Technology Development 
Specialist, Office of Technology Transfer, National Heart, Lung, and 
Blood Institute, Phone: (301) 594-4273; [email protected].

    Dated: August 21, 2017.
Michael Shmilovich,
Senior Licensing and Patenting Manager, National Heart, Lung, and Blood 
Institute, Office of Technology Transfer and Development.
[FR Doc. 2017-18670 Filed 9-1-17; 8:45 am]
BILLING CODE 4140-01-P